Economic evaluation of the societal costs of hepatitis B in South Korea

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 3, 2001, Pages 301-308

  Yang, Bong Min ^a   Paik, Seung Woon ^b   Hahn, Oh Serk ^c   Yi, Deok Hee ^d   Choi, Moon Suk ^b   Payne, Sarah ^e  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Health Insurance Review Agency   (South Korea)

^d IL   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cost of illness analysis; Hepatitis B; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; COST; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEPATITIS B; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SOCIETY; SOUTH KOREA;

EID: 0035042816     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02443.x     Document Type: Article

References (11)

1. Hepatitis B infection
2. Data analysis over 20 years - Chronic hepatitis and cirrhosis patients, natural progression and survival rate
3. Recent changes in HBV carrier rate among Koreans
4. Hepatitis B in the Asian-Pacific region
5. Strategy for vaccination against hepatitis B in areas with high endemicity - Focus on Korea
6. The role of health insurance in the growth of the private health sector in Korea